It has been shown that GE can reactivate methylation-silenced tumor suppressor BTG3 gene by CpG demethylation and inhibition of DNMT and MBD2 activity in HEK- 293 renal cell carcinoma (Majid et al., 2009). The gene discussed is MBD2; the disease is hereditary clear cell renal cell carcinoma.